Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Serge Saxonov. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Serge Saxonov har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:TXG / 10x Genomics, Inc. | Chief Executive Officer, Director | 945 892 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Serge Saxonov. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp TXG / 10x Genomics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i TXG / 10x Genomics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i TXG / 10x Genomics, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Serge Saxonov som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-08-26 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −9 348 | 945 892 | −0,98 | 13,79 | −128 881 | 13 041 013 | |
2025-06-11 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −1 000 | 955 240 | −0,10 | ||||
2025-06-02 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −3 000 | 1 080 625 | −0,28 | ||||
2025-05-27 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −9 343 | 1 083 625 | −0,85 | 8,30 | −77 540 | 8 993 329 | |
2025-03-19 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
A - Award | 171 428 | 1 092 968 | 18,60 | ||||
2025-03-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 50 000 | 921 540 | 5,74 | 1,20 | 60 000 | 1 105 848 | |
2025-03-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −7 942 | 871 540 | −0,90 | 10,63 | −84 393 | 9 261 158 |
2025-02-26 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −5 092 | 879 482 | −0,58 | 11,07 | −56 346 | 9 731 996 | |
2024-12-23 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 12 000 | 884 574 | 1,38 | 1,20 | 14 400 | 1 061 489 | |
2024-11-25 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −6 693 | 872 574 | −0,76 | 13,69 | −91 612 | 11 943 618 | |
2024-11-25 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −1 850 | 879 267 | −0,21 | ||||
2024-11-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −1 350 | 881 117 | −0,15 | ||||
2024-08-26 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −6 749 | 882 467 | −0,76 | 22,53 | −152 053 | 19 881 717 | |
2024-05-31 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −425 | 889 216 | −0,05 | ||||
2024-05-23 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −4 877 | 889 641 | −0,55 | 24,30 | −118 529 | 21 621 479 | |
2024-03-25 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
A - Award | 88 854 | 894 518 | 11,03 | ||||
2024-03-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −1 086 | 805 664 | −0,13 | ||||
2024-03-06 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −4 660 | 842 900 | −0,55 | 44,00 | −205 021 | 37 084 144 | |
2024-02-26 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −2 821 | 847 560 | −0,33 | 46,34 | −130 737 | 39 279 575 | |
2024-02-20 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 700 | 850 381 | −0,20 | 49,43 | −84 032 | 42 034 843 |
2024-02-20 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −3 300 | 852 081 | −0,39 | 48,58 | −160 300 | 41 390 516 |
2024-02-13 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 000 | 855 381 | −0,12 | 49,53 | −49 530 | 42 367 106 |
2024-01-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 035 | 856 381 | −0,12 | 45,65 | −47 244 | 39 090 967 |
2024-01-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 965 | 857 416 | −0,34 | 45,10 | −133 712 | 38 666 632 |
2023-12-29 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 14 935 | 860 381 | 1,77 | 1,20 | 17 922 | 1 032 457 | |
2023-12-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 700 | 845 446 | −0,20 | 55,15 | −93 749 | 46 623 388 |
2023-12-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −300 | 847 146 | −0,04 | 54,39 | −16 316 | 46 073 475 |
2023-11-27 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −3 723 | 847 446 | −0,44 | 43,72 | −162 751 | 37 046 102 | |
2023-11-27 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −3 757 | 851 169 | −0,44 | 43,34 | −162 816 | 36 886 856 | |
2023-11-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 000 | 854 926 | −0,23 | 39,52 | −79 041 | 33 786 932 |
2023-10-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 979 | 856 926 | −0,23 | 39,51 | −78 187 | 33 855 775 |
2023-10-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −21 | 858 905 | 0,00 | 39,50 | −830 | 33 926 748 |
2023-09-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −3 167 | 858 926 | −0,37 | ||||
2023-09-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −80 | 862 093 | −0,01 | 49,82 | −3 986 | 42 949 473 |
2023-09-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 920 | 862 173 | −0,22 | 49,35 | −94 754 | 42 549 014 |
2023-08-24 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −3 757 | 864 093 | −0,43 | 45,78 | −172 000 | 39 559 128 | |
2023-08-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −17 | 867 850 | 0,00 | 50,42 | −857 | 43 756 997 |
2023-08-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 983 | 867 867 | −0,23 | 50,10 | −99 355 | 43 483 001 |
2023-07-21 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −40 000 | 869 850 | −4,40 | 60,03 | −2 401 088 | 52 214 660 |
2023-07-21 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 20 845 | 909 850 | 2,34 | 5,04 | 105 059 | 4 585 644 | |
2023-07-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 149 | 889 005 | −0,13 | 58,37 | −67 064 | 51 888 910 |
2023-07-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −851 | 890 154 | −0,10 | 57,61 | −49 026 | 51 281 950 |
2023-06-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −51 | 891 005 | −0,01 | 59,15 | −3 017 | 52 702 946 |
2023-06-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 209 | 891 056 | −0,14 | 58,53 | −70 758 | 52 150 122 |
2023-06-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −740 | 892 265 | −0,08 | 57,50 | −42 553 | 51 308 628 |
2023-06-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −185 | 893 005 | −0,02 | ||||
2023-05-23 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −2 068 | 893 190 | −0,23 | 55,06 | −113 867 | 49 180 203 | |
2023-05-23 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −534 | 895 258 | −0,06 | 55,06 | −29 404 | 49 296 487 | |
2023-05-23 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −460 | 27 | −94,46 | ||||
2023-05-17 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 506 | 895 792 | −0,17 | 53,57 | −80 669 | 47 983 278 |
2023-05-17 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −494 | 897 298 | −0,06 | 52,70 | −26 032 | 47 285 002 |
2023-04-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −76 | 897 792 | −0,01 | 55,28 | −4 201 | 49 629 852 |
2023-04-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −283 | 897 868 | −0,03 | 54,64 | −15 462 | 49 056 545 |
2023-04-18 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 641 | 898 151 | −0,18 | 53,61 | −87 976 | 48 151 222 |
2023-03-23 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
A - Award | 36 387 | 899 792 | 4,21 | ||||
2023-03-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −303 | 863 405 | −0,04 | 49,28 | −14 932 | 42 549 289 |
2023-03-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 697 | 863 708 | −0,20 | 48,81 | −82 824 | 42 154 133 |
2023-03-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −260 | 487 | −34,81 | ||||
2023-02-24 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −1 941 | 909 715 | −0,21 | 47,75 | −92 689 | 43 441 893 | |
2022-12-14 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −1 740 | 747 | −69,96 | ||||
2022-12-14 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 3 000 | 911 656 | 0,33 | 1,20 | 3 600 | 1 093 987 | |
2022-11-23 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −1 887 | 974 926 | −0,19 | 34,07 | −64 281 | 33 211 147 | |
2022-11-23 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −789 | 976 813 | −0,08 | 34,06 | −26 877 | 33 275 037 | |
2022-09-14 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 11 500 | 977 602 | 1,19 | 1,20 | 13 800 | 1 173 122 | |
2022-08-25 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −2 715 | 966 102 | −0,28 | 35,19 | −95 544 | 33 998 385 | |
2022-06-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −1 651 | 2 487 | −39,90 | ||||
2022-05-25 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −2 656 | 968 817 | −0,27 | 48,76 | −129 516 | 47 243 005 | |
2022-03-24 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (Right to Buy) |
A - Award | 146 827 | 146 827 | |||||
2022-03-24 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
A - Award | 58 731 | 971 473 | 6,43 | ||||
2022-02-24 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −551 | 912 742 | −0,06 | 78,60 | −43 309 | 71 741 795 | |
2022-02-10 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −3 038 | 42 521 | −6,67 | |||
2022-02-10 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 397 | 913 293 | −0,26 | 91,04 | −218 228 | 83 148 113 |
2022-02-10 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −4 503 | 915 690 | −0,49 | 90,30 | −406 618 | 82 686 166 |
2022-02-10 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −4 200 | 920 193 | −0,45 | 89,19 | −374 590 | 82 070 357 |
2022-02-10 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −900 | 924 393 | −0,10 | 88,17 | −79 349 | 81 500 126 |
2022-02-10 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 3 038 | 925 293 | 0,33 | 11,48 | 34 876 | 10 622 364 |
2022-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −3 037 | 45 559 | −6,25 | |||
2022-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −500 | 922 255 | −0,05 | 145,33 | −72 663 | 134 027 630 |
2022-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 400 | 922 755 | −0,15 | 144,78 | −202 695 | 133 598 130 |
2022-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −700 | 924 155 | −0,08 | 143,11 | −100 179 | 132 258 132 |
2022-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 932 | 924 855 | −0,32 | 141,72 | −415 517 | 131 068 508 |
2022-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −5 368 | 927 787 | −0,58 | 140,96 | −756 663 | 130 779 000 |
2022-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −3 100 | 933 155 | −0,33 | 139,82 | −433 444 | 130 474 385 |
2022-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 000 | 936 255 | −0,11 | 138,86 | −138 864 | 130 011 740 |
2022-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 3 037 | 937 255 | 0,33 | 11,48 | 34 865 | 10 759 687 |
2021-12-30 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | −56 363 | 52 535 | −51,76 | ||||
2021-12-30 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 56 363 | 934 218 | 6,42 | 1,20 | 67 636 | 1 121 062 | |
2021-12-30 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −360 | 4 138 | −8,00 | ||||
2021-12-09 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −3 037 | 48 596 | −5,88 | |||
2021-12-09 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −5 209 | 53 323 | −8,90 | |||
2021-12-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −754 | 877 855 | −0,09 | 148,60 | −112 043 | 130 447 673 |
2021-12-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 370 | 878 609 | −0,27 | 147,96 | −350 673 | 130 002 063 |
2021-12-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −6 480 | 880 979 | −0,73 | 147,05 | −952 882 | 129 547 698 |
2021-12-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −571 | 887 459 | −0,06 | 145,79 | −83 247 | 129 384 689 |
2021-12-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −672 | 888 030 | −0,08 | 144,27 | −96 950 | 128 116 355 |
2021-12-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −3 187 | 888 702 | −0,36 | 143,36 | −456 881 | 127 402 364 |
2021-12-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −766 | 891 889 | −0,09 | 142,40 | −109 075 | 127 000 891 |
2021-12-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −200 | 892 655 | −0,02 | 138,86 | −27 772 | 123 954 073 |
2021-12-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 3 037 | 892 855 | 0,34 | 11,48 | 34 865 | 10 249 975 |
2021-12-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 5 209 | 889 818 | 0,59 | 5,04 | 26 253 | 4 484 683 |
2021-11-24 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −772 | 884 609 | −0,09 | 148,38 | −114 550 | 131 259 256 | |
2021-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −3 037 | 51 633 | −5,56 | |||
2021-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −5 208 | 58 532 | −8,17 | |||
2021-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −200 | 885 381 | −0,02 | 163,14 | −32 628 | 144 441 056 |
2021-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −5 613 | 885 581 | −0,63 | 161,94 | −908 962 | 143 409 836 |
2021-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −5 946 | 891 194 | −0,66 | 161,06 | −957 687 | 143 539 270 |
2021-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −3 241 | 897 140 | −0,36 | 160,26 | −519 410 | 143 777 720 |
2021-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 3 037 | 900 381 | 0,34 | 11,48 | 34 865 | 10 336 374 |
2021-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 5 208 | 897 344 | 0,58 | 5,04 | 26 248 | 4 522 614 |
2021-10-07 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −3 460 | 54 670 | −5,95 | |||
2021-10-07 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −5 208 | 63 740 | −7,55 | |||
2021-10-07 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −300 | 892 136 | −0,03 | 146,12 | −43 835 | 130 355 968 |
2021-10-07 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 720 | 892 436 | −0,19 | 145,42 | −250 126 | 129 780 006 |
2021-10-07 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 900 | 894 156 | −0,21 | 144,40 | −274 361 | 129 116 573 |
2021-10-07 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −6 056 | 896 056 | −0,67 | 143,40 | −868 409 | 128 491 205 |
2021-10-07 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −5 024 | 902 112 | −0,55 | 142,47 | −715 760 | 128 522 183 |
2021-10-07 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 3 460 | 907 136 | 0,38 | 11,48 | 39 721 | 10 413 921 |
2021-10-07 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 5 208 | 903 676 | 0,58 | 5,04 | 26 248 | 4 554 527 |
2021-09-09 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −9 791 | 58 130 | −14,42 | |||
2021-09-09 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −5 209 | 68 948 | −7,02 | |||
2021-09-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −400 | 898 468 | −0,04 | 191,12 | −76 450 | 171 719 696 |
2021-09-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −3 759 | 898 868 | −0,42 | 190,44 | −715 863 | 171 180 242 |
2021-09-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 800 | 902 627 | −0,31 | 189,81 | −531 470 | 171 328 353 |
2021-09-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 414 | 905 427 | −0,16 | 188,51 | −266 550 | 170 680 142 |
2021-09-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 025 | 906 841 | −0,22 | 187,45 | −379 585 | 169 986 801 |
2021-09-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 702 | 908 866 | −0,30 | 186,74 | −504 564 | 169 719 001 |
2021-09-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 200 | 911 568 | −0,13 | 185,50 | −222 604 | 169 099 054 |
2021-09-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −700 | 912 768 | −0,08 | 184,49 | −129 146 | 168 400 402 |
2021-09-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 9 791 | 913 468 | 1,08 | 11,48 | 112 401 | 10 486 613 |
2021-09-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 5 209 | 903 677 | 0,58 | 5,04 | 26 253 | 4 554 532 |
2021-09-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −360 | 4 498 | −7,41 | ||||
2021-08-25 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −742 | 903 326 | −0,08 | 161,85 | −120 091 | 146 201 055 | |
2021-08-04 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −9 792 | 67 921 | −12,60 | |||
2021-08-04 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −5 208 | 74 157 | −6,56 | |||
2021-08-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −904 | 904 068 | −0,10 | 179,35 | −162 129 | 162 141 341 |
2021-08-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −7 946 | 904 972 | −0,87 | 178,47 | −1 418 127 | 161 510 896 |
2021-08-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −4 450 | 912 918 | −0,49 | 177,56 | −790 130 | 162 095 346 |
2021-08-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 700 | 917 368 | −0,18 | 176,52 | −300 085 | 161 934 075 |
2021-08-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 9 792 | 919 068 | 1,08 | 11,48 | 112 412 | 10 550 901 |
2021-08-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 5 208 | 909 276 | 0,58 | 5,04 | 26 248 | 4 582 751 |
2021-07-08 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −9 792 | 77 713 | −11,19 | |||
2021-07-08 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −5 208 | 79 365 | −6,16 | |||
2021-07-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −100 | 904 068 | −0,01 | 196,97 | −19 697 | 178 076 082 |
2021-07-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −500 | 904 168 | −0,06 | 196,33 | −98 164 | 177 513 405 |
2021-07-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 000 | 904 668 | −0,22 | 195,12 | −390 247 | 176 522 167 |
2021-07-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 756 | 906 668 | −0,30 | 194,13 | −535 015 | 176 008 920 |
2021-07-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −3 027 | 909 424 | −0,33 | 193,27 | −585 037 | 175 767 014 |
2021-07-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −4 017 | 912 451 | −0,44 | 192,20 | −772 061 | 175 371 714 |
2021-07-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 700 | 916 468 | −0,19 | 191,07 | −324 811 | 175 105 142 |
2021-07-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −900 | 918 168 | −0,10 | 190,12 | −171 105 | 174 559 529 |
2021-07-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 9 792 | 919 068 | 1,08 | 11,48 | 112 412 | 10 550 901 |
2021-07-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 5 208 | 909 276 | 0,58 | 5,04 | 26 248 | 4 582 751 |
2021-06-10 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −9 791 | 87 505 | −10,06 | |||
2021-06-10 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −5 209 | 84 573 | −5,80 | |||
2021-06-10 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 361 | 904 068 | −0,26 | 187,92 | −443 668 | 169 888 300 |
2021-06-10 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −5 239 | 906 429 | −0,57 | 186,91 | −979 241 | 169 423 998 |
2021-06-10 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −4 600 | 911 668 | −0,50 | 185,89 | −855 073 | 169 465 771 |
2021-06-10 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 200 | 916 268 | −0,24 | 185,05 | −407 103 | 169 552 461 |
2021-06-10 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −600 | 918 468 | −0,07 | 184,17 | −110 503 | 169 155 813 |
2021-06-10 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 9 791 | 919 068 | 1,08 | 11,48 | 112 401 | 10 550 901 |
2021-06-10 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 5 209 | 909 277 | 0,58 | 5,04 | 26 253 | 4 582 756 |
2021-06-10 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −200 | 904 068 | −0,02 | ||||
2021-05-26 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | −771 | 904 268 | −0,09 | 162,66 | −125 411 | 147 087 871 | |
2021-05-26 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
A - Award | 61 428 | 61 428 | |||||
2021-05-26 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
A - Award | 24 571 | 905 039 | 2,79 | ||||
2021-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −9 792 | 97 296 | −9,14 | |||
2021-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −5 208 | 89 782 | −5,48 | |||
2021-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −200 | 880 468 | −0,02 | 188,74 | −37 749 | 166 183 933 |
2021-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −100 | 880 668 | −0,01 | 186,75 | −18 675 | 164 464 749 |
2021-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 100 | 880 768 | −0,12 | 185,91 | −204 505 | 163 746 397 |
2021-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 951 | 881 868 | −0,33 | 185,04 | −546 042 | 163 177 592 |
2021-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −6 644 | 884 819 | −0,75 | 184,20 | −1 223 855 | 162 987 641 |
2021-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 100 | 891 463 | −0,24 | 183,06 | −384 418 | 163 187 740 |
2021-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 200 | 893 563 | −0,13 | 182,14 | −218 570 | 162 755 084 |
2021-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −505 | 894 763 | −0,06 | 180,94 | −91 372 | 161 894 301 |
2021-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −200 | 895 268 | −0,02 | 179,70 | −35 941 | 160 884 136 |
2021-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 9 792 | 895 468 | 1,11 | 11,48 | 112 412 | 10 279 973 |
2021-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 5 208 | 885 676 | 0,59 | 5,04 | 26 248 | 4 463 807 |
2021-04-08 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −9 792 | 107 088 | −8,38 | |||
2021-04-08 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −5 208 | 94 990 | −5,20 | |||
2021-04-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −100 | 880 468 | −0,01 | 199,41 | −19 941 | 175 574 124 |
2021-04-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −800 | 880 568 | −0,09 | 198,69 | −158 953 | 174 961 201 |
2021-04-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 849 | 881 368 | −0,32 | 197,47 | −562 605 | 174 047 793 |
2021-04-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −5 428 | 884 217 | −0,61 | 196,61 | −1 067 222 | 173 849 707 |
2021-04-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 097 | 889 645 | −0,12 | 195,81 | −214 807 | 174 204 145 |
2021-04-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 826 | 890 742 | −0,20 | 194,44 | −355 052 | 173 198 101 |
2021-04-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 900 | 892 568 | −0,21 | 193,48 | −367 604 | 172 690 308 |
2021-04-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −200 | 894 468 | −0,02 | 192,46 | −38 493 | 172 153 784 |
2021-04-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −800 | 894 668 | −0,09 | 190,58 | −152 465 | 170 506 991 |
2021-04-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 9 792 | 895 468 | 1,11 | 11,48 | 112 412 | 10 279 973 |
2021-04-08 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 5 208 | 885 676 | 0,59 | 5,04 | 26 248 | 4 463 807 |
2021-03-16 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −9 791 | 116 880 | −7,73 | |||
2021-03-16 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −5 209 | 100 198 | −4,94 | |||
2021-03-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −3 174 | 880 468 | −0,36 | 159,35 | −505 768 | 140 300 110 |
2021-03-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 933 | 883 642 | −0,22 | 158,49 | −306 355 | 140 045 770 |
2021-03-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 384 | 885 575 | −0,27 | 157,42 | −375 285 | 139 405 534 |
2021-03-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −3 105 | 887 959 | −0,35 | 156,35 | −485 463 | 138 831 324 |
2021-03-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 904 | 891 064 | −0,32 | 155,35 | −451 147 | 138 430 000 |
2021-03-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 500 | 893 968 | −0,17 | 154,37 | −231 550 | 137 999 158 |
2021-03-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 9 791 | 895 468 | 1,11 | 11,48 | 112 401 | 10 279 973 |
2021-03-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 5 209 | 885 677 | 0,59 | 5,04 | 26 253 | 4 463 812 |
2021-02-03 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −892 | 126 671 | −0,70 | |||
2021-02-03 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −9 108 | 105 407 | −7,95 | |||
2021-02-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −200 | 880 468 | −0,02 | 178,98 | −35 796 | 157 586 163 |
2021-02-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −600 | 880 668 | −0,07 | 177,99 | −106 792 | 156 747 191 |
2021-02-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 410 | 881 268 | −0,16 | 176,99 | −249 557 | 155 976 328 |
2021-02-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −4 815 | 882 678 | −0,54 | 175,92 | −847 046 | 155 279 037 |
2021-02-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 575 | 887 493 | −0,29 | 175,22 | −451 192 | 155 506 701 |
2021-02-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −400 | 890 068 | −0,04 | 174,15 | −69 660 | 155 005 342 |
2021-02-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 892 | 890 468 | 0,10 | 11,48 | 10 240 | 10 222 573 |
2021-02-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 9 108 | 889 576 | 1,03 | 5,04 | 45 904 | 4 483 463 |
2021-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −10 000 | 114 515 | −8,03 | |||
2021-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −200 | 880 468 | −0,02 | 141,91 | −28 382 | 124 947 214 |
2021-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 523 | 880 668 | −0,17 | 140,83 | −214 486 | 124 025 619 |
2021-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −6 277 | 882 191 | −0,71 | 139,91 | −878 233 | 123 429 901 |
2021-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 000 | 888 468 | −0,22 | 139,08 | −278 160 | 123 568 218 |
2021-01-06 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 890 468 | 1,14 | 5,04 | 50 400 | 4 487 959 |
2020-12-23 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | −962 | 108 898 | −0,88 | ||||
2020-12-23 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | −2 667 | 0 | −100,00 | ||||
2020-12-23 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 962 | 880 468 | 0,11 | 1,20 | 1 154 | 1 056 562 | |
2020-12-23 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 2 667 | 879 506 | 0,30 | 1,07 | 2 854 | 941 071 | |
2020-12-23 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | 15 000 | 876 839 | 1,74 | ||||
2020-12-23 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −15 000 | 89 960 | −14,29 | ||||
2020-12-23 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | 104 960 | 104 960 | |||||
2020-12-23 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −104 960 | 861 839 | −10,86 | ||||
2020-12-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −382 | 966 799 | −0,04 | ||||
2020-12-03 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −3 750 | 124 515 | −2,92 | |||
2020-12-03 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −6 250 | 109 860 | −5,38 | |||
2020-12-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −333 | 967 181 | −0,03 | 153,84 | −51 230 | 148 794 897 |
2020-12-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 174 | 967 514 | −0,22 | 153,26 | −333 179 | 148 277 713 |
2020-12-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 091 | 969 688 | −0,11 | 151,92 | −165 749 | 147 318 977 |
2020-12-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −3 398 | 970 779 | −0,35 | 151,02 | −513 174 | 146 609 472 |
2020-12-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −3 004 | 974 177 | −0,31 | 150,01 | −450 620 | 146 132 980 |
2020-12-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 3 750 | 977 181 | 0,39 | 5,04 | 18 900 | 4 924 992 |
2020-12-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 6 250 | 973 431 | 0,65 | 1,20 | 7 500 | 1 168 117 |
2020-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −2 924 | 128 265 | −2,23 | |||
2020-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −200 | 967 181 | −0,02 | 138,48 | −27 696 | 133 935 225 |
2020-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 524 | 967 381 | −0,16 | 137,50 | −209 549 | 133 014 114 |
2020-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 000 | 968 905 | −0,10 | 136,55 | −136 547 | 132 301 071 |
2020-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −200 | 969 905 | −0,02 | 135,54 | −27 107 | 131 456 074 |
2020-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 2 924 | 970 105 | 0,30 | 5,04 | 14 737 | 4 889 329 |
2020-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −826 | 131 189 | −0,63 | |||
2020-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −6 250 | 116 110 | −5,11 | |||
2020-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −900 | 967 181 | −0,09 | 138,54 | −124 686 | 133 993 256 |
2020-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −500 | 968 081 | −0,05 | 137,10 | −68 552 | 132 727 777 |
2020-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −4 052 | 968 581 | −0,42 | 136,13 | −551 587 | 131 850 026 |
2020-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 624 | 972 633 | −0,17 | 135,45 | −219 978 | 131 747 711 |
2020-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 826 | 974 257 | 0,08 | 5,04 | 4 163 | 4 910 255 |
2020-11-04 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 6 250 | 973 431 | 0,65 | 1,20 | 7 500 | 1 168 117 |
2020-10-05 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −3 750 | 132 015 | −2,76 | |||
2020-10-05 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −6 250 | 122 360 | −4,86 | |||
2020-10-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 250 | 967 181 | −0,23 | 126,08 | −283 674 | 121 939 666 |
2020-10-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −6 150 | 969 431 | −0,63 | 125,54 | −772 095 | 121 706 149 |
2020-10-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 600 | 975 581 | −0,16 | 124,34 | −198 952 | 121 308 619 |
2020-10-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 3 750 | 977 181 | 0,39 | 5,04 | 18 900 | 4 924 992 |
2020-10-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 6 250 | 973 431 | 0,65 | 1,20 | 7 500 | 1 168 117 |
2020-09-03 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −14 000 | 2 667 | −84,00 | |||
2020-09-03 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −7 360 | 135 765 | −5,14 | |||
2020-09-03 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −2 640 | 128 610 | −2,01 | |||
2020-09-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −200 | 967 181 | −0,02 | 115,52 | −23 105 | 111 733 585 |
2020-09-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −3 014 | 967 381 | −0,31 | 114,74 | −345 827 | 110 997 586 |
2020-09-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −5 086 | 970 395 | −0,52 | 113,82 | −578 892 | 110 451 038 |
2020-09-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 700 | 975 481 | −0,17 | 112,86 | −191 866 | 110 095 029 |
2020-09-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 14 000 | 977 181 | 1,45 | 1,07 | 14 980 | 1 045 584 |
2020-09-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 7 360 | 963 181 | 0,77 | 5,04 | 37 094 | 4 854 432 |
2020-09-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 2 640 | 955 821 | 0,28 | 1,20 | 3 168 | 1 146 985 |
2020-08-05 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −10 000 | 143 125 | −6,53 | |||
2020-08-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −100 | 953 181 | −0,01 | 101,31 | −10 131 | 96 566 767 |
2020-08-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −700 | 953 281 | −0,07 | 100,63 | −70 440 | 95 927 332 |
2020-08-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −6 100 | 953 981 | −0,64 | 99,38 | −606 208 | 94 805 105 |
2020-08-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −3 100 | 960 081 | −0,32 | 98,87 | −306 496 | 94 923 016 |
2020-08-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 963 181 | 1,05 | 5,04 | 50 400 | 4 854 432 |
2020-07-02 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −10 000 | 153 125 | −6,13 | |||
2020-07-02 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −300 | 953 181 | −0,03 | 88,88 | −26 665 | 84 721 873 |
2020-07-02 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −4 500 | 953 481 | −0,47 | 87,99 | −395 947 | 83 895 077 |
2020-07-02 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −5 200 | 957 981 | −0,54 | 87,16 | −453 228 | 83 496 858 |
2020-07-02 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 963 181 | 1,05 | 5,04 | 50 400 | 4 854 432 |
2020-06-03 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −10 000 | 163 125 | −5,78 | |||
2020-06-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −500 | 953 181 | −0,05 | 81,97 | −40 985 | 78 132 247 |
2020-06-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −3 500 | 953 681 | −0,37 | 81,51 | −285 301 | 77 739 021 |
2020-06-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 100 | 957 181 | −0,11 | 80,14 | −88 149 | 76 704 178 |
2020-06-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 700 | 958 281 | −0,18 | 79,35 | −134 888 | 76 035 477 |
2020-06-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 100 | 959 981 | −0,22 | 78,11 | −164 031 | 74 984 116 |
2020-06-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 100 | 962 081 | −0,11 | 77,17 | −84 888 | 74 244 657 |
2020-06-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 963 181 | 1,05 | 5,04 | 50 400 | 4 854 432 |
2020-05-20 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
G - Gift | −1 500 | 953 181 | −0,16 | ||||
2020-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −9 167 | 173 125 | −5,03 | |||
2020-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −833 | 131 250 | −0,63 | |||
2020-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 502 | 954 681 | −0,26 | 78,72 | −196 963 | 75 154 780 |
2020-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −2 197 | 957 183 | −0,23 | 77,66 | −170 610 | 74 330 716 |
2020-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −5 301 | 959 380 | −0,55 | 76,65 | −406 339 | 73 539 643 |
2020-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 9 167 | 964 681 | 0,96 | 5,04 | 46 202 | 4 861 992 |
2020-05-05 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 833 | 955 514 | 0,09 | 1,20 | 1 000 | 1 146 617 |
2020-04-23 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
A - Award | 235 733 | 235 733 | |||||
2020-04-07 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | −4 167 | 16 667 | −20,00 | ||||
2020-04-07 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 4 167 | 954 681 | 0,44 | 1,07 | 4 459 | 1 021 509 | |
2020-04-03 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −10 000 | 132 083 | −7,04 | |||
2020-04-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −200 | 950 514 | −0,02 | 59,82 | −11 964 | 56 859 747 |
2020-04-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −4 716 | 950 714 | −0,49 | 58,34 | −275 137 | 55 465 796 |
2020-04-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −5 084 | 955 430 | −0,53 | 57,76 | −293 644 | 55 184 108 |
2020-04-03 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 960 514 | 1,05 | 1,20 | 12 000 | 1 152 617 |
2020-03-25 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | −12 500 | 20 834 | −37,50 | ||||
2020-03-25 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 12 500 | 950 514 | 1,33 | 1,07 | 13 375 | 1 017 050 | |
2020-03-09 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −1 667 | 142 083 | −1,16 | |||
2020-03-09 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | X | −8 333 | 33 334 | −20,00 | |||
2020-03-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −447 | 938 014 | −0,05 | 70,01 | −31 293 | 65 666 327 |
2020-03-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −822 | 938 461 | −0,09 | 69,34 | −57 000 | 65 075 607 |
2020-03-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −618 | 939 283 | −0,07 | 68,13 | −42 103 | 63 991 942 |
2020-03-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −600 | 939 901 | −0,06 | 66,86 | −40 116 | 62 841 781 |
2020-03-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −800 | 940 501 | −0,08 | 65,78 | −52 628 | 61 870 858 |
2020-03-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 098 | 941 301 | −0,12 | 64,91 | −71 273 | 61 101 825 |
2020-03-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −3 767 | 942 399 | −0,40 | 63,91 | −240 761 | 60 231 736 |
2020-03-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
S - Sale | X | −1 848 | 946 166 | −0,19 | 62,91 | −116 262 | 59 525 763 |
2020-03-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 1 667 | 948 014 | 0,18 | 1,20 | 2 000 | 1 137 617 |
2020-03-09 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | X | 8 333 | 946 347 | 0,89 | 1,07 | 8 916 | 1 012 591 |
2020-01-14 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
A - Award | 150 000 | 150 000 | |||||
2019-10-15 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | −3 037 | 127 563 | −2,33 | ||||
2019-10-15 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | −5 208 | 182 292 | −2,78 | ||||
2019-10-15 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | −4 167 | 112 500 | −3,57 | ||||
2019-10-15 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | −4 167 | 112 500 | −3,57 | ||||
2019-10-15 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
M - Exercise | −6 250 | 143 750 | −4,17 | ||||
2019-10-15 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 3 037 | 938 014 | 0,32 | 11,48 | 34 865 | 10 768 401 | |
2019-10-15 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 5 208 | 934 977 | 0,56 | 5,04 | 26 248 | 4 712 284 | |
2019-10-15 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 4 167 | 929 769 | 0,45 | 1,20 | 5 000 | 1 115 723 | |
2019-10-15 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 6 250 | 925 602 | 0,68 | 1,20 | 7 500 | 1 110 722 | |
2019-10-15 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
M - Exercise | 4 167 | 919 352 | 0,46 | 1,07 | 4 459 | 983 707 | |
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
J - Other | 130 600 | 130 600 | |||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
J - Other | −130 600 | 0 | −100,00 | ||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
J - Other | 187 500 | 187 500 | |||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
J - Other | −187 500 | 0 | −100,00 | ||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
J - Other | 116 667 | 116 667 | |||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
J - Other | −116 667 | 0 | −100,00 | ||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
J - Other | 150 000 | 150 000 | |||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
J - Other | −150 000 | 0 | −100,00 | ||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
J - Other | 45 834 | 45 834 | |||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Stock Option (right to buy) |
J - Other | −45 834 | 0 | −100,00 | ||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Class B Common Stock |
J - Other | 1 750 000 | 1 750 000 | |||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
J - Other | −1 750 000 | 0 | −100,00 | ||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Class B Common Stock |
J - Other | 1 250 000 | 1 250 000 | |||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
J - Other | −1 250 000 | 0 | −100,00 | ||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Class B Common Stock |
C - Conversion | 31 865 | 31 865 | |||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Series A-1 Preferred Stock |
C - Conversion | −31 865 | 0 | −100,00 | ||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Class A Common Stock |
J - Other | 915 185 | 915 185 | |||||
2019-09-16 |
|
4 | TXG |
10x Genomics, Inc.
Class B Common Stock |
J - Other | −915 185 | 0 | −100,00 | ||||
2019-09-11 | 3 | TXG |
10x Genomics, Inc.
Class B Common Stock |
1 830 370 | ||||||||
2019-09-11 | 3 | TXG |
10x Genomics, Inc.
Class B Common Stock |
1 830 370 | ||||||||
2019-09-11 | 3 | TXG |
10x Genomics, Inc.
Class B Common Stock |
1 830 370 |